| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $358.0M | — | +27.9% |
| Cost of Revenue | $89.1M | — | +31.6% |
| Gross Profit | $268.9M | — | +26.8% |
| R&D Expense | $80.0M | — | +15.4% |
| SG&A Expense | $53.1M | — | +23.4% |
| Operating Income | $1.7M | — | +107.3% |
| Pre-tax Income | $10.7M | — | +170.7% |
| Income Tax | $1.7M | — | +257.8% |
| Net Income | $9.0M | — | +164.1% |
| EPS (Basic) | $0.03 | — | +160.0% |
| EPS (Diluted) | $0.03 | — | +160.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $984.6M | -7.5% | +10.8% |
| Accounts Receivable | $72.3M | +19.1% | +34.1% |
| Current Assets | $1.15B | -4.9% | +13.8% |
| Total Assets | $1.52B | -3.6% | +13.1% |
| Current Liabilities | $271.0M | -4.0% | +40.6% |
| Total Liabilities | $370.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $34.3M | — | +138.7% |
| Capital Expenditures | $11.7M | — | +334.5% |
| Investing Cash Flow | -$15.7M | — | -103.0% |
| Financing Cash Flow | -$98.8M | — | — |
| Free Cash Flow | $22.6M | — | +93.7% |
| +30.6% |
| Stockholders' Equity | $1.15B | -3.6% | +8.4% |